Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cardiol Therapeutics Inc (CRDL) COM NPV CL A

Sell:5.69 CAD Buy:5.74 CAD Change: 0.34 CAD (5.98%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Sell:5.69 CAD
Buy:5.74 CAD
Change: 0.34 CAD (5.98%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
Sell:5.69 CAD
Buy:5.74 CAD
Change: 0.34 CAD (5.98%)
Market closed |  Prices as at close on 27 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cardiol Therapeutics Inc is a Canada-based company engaged in the pharmaceutical business sector. The Company is focused on the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. It has research programs focused on development of nanotherapeutics to treat heart failure underway. The Company invests in development of formulations for three medical markets: commercializing a line of purity pharmaceutically-manufactured cannabidiol products in the market for medical cannabinoids; development of nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure, a cause of death and hospitalization, and pursuing an immunotherapeutics program commencing with a cancer immunotherapeutic in combination with cannabinoids for treating Glioblastoma Multiforme.

Contact details

Address:
602-2265 Upper Middle Road East
OAKVILLE
L6H 0G5
Canada
Telephone:
+1 (289) 9100850
Website:
www.cardiolrx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CRDL
ISIN:
CA14161Y2006
Market cap:
244.37 million CAD
Shares in issue:
42.95 million
Sector:
Pharmaceuticals
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Eldon Smith
    Chairman of the Board
  • David Elsley
    President, Chief Executive Officer, Director
  • Chris Waddick
    Chief Financial Officer, Corporate Secretary
  • Bernard Lim
    Chief Operating Officer
  • Anthony Bolton
    Director of Research
  • Andrew Hamer
    Chief Medical Officer
  • Thomas Moffatt
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.